Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	tau-protein kinase activity	MARK1 MARK3 MARK4 BRSK1 FYN	4.34e-07	22	144	5	GO:0050321
GeneOntologyMolecularFunction	tau protein binding	MARK1 MARK3 MARK4 BRSK1 FYN	1.97e-05	46	144	5	GO:0048156
GeneOntologyMolecularFunction	structural constituent of skin epidermis	FLG KRT6A KRT6B KRT6C	2.57e-04	43	144	4	GO:0030280
GeneOntologyCellularComponent	keratohyalin granule	FLG HRNR FLG2	3.24e-06	5	145	3	GO:0036457
GeneOntologyCellularComponent	polymeric cytoskeletal fiber	KRT6A KRT6B DYNC2H1 TOGARAM1 DNAH7 SMTN ARHGAP4 DLC1 NDRG1 KRT6C PDE4DIP KIF19 PKP2 KIF18B SPAG17 FYN PCNT	1.69e-04	899	145	17	GO:0099513
HumanPheno	Ear pain	TRAF7 KRT6A KRT6B PDGFB	9.55e-06	15	49	4	HP:0030766
Domain	MARK/par1	MARK1 MARK3 MARK4	1.68e-06	4	141	3	IPR033624
Domain	KA1	MARK1 MARK3 MARK4	4.17e-06	5	141	3	PF02149
Domain	KA1_dom	MARK1 MARK3 MARK4	4.17e-06	5	141	3	IPR001772
Domain	KA1	MARK1 MARK3 MARK4	4.17e-06	5	141	3	PS50032
Domain	-	MARK1 MARK3 MARK4	4.17e-06	5	141	3	3.30.310.80
Domain	KA1/Ssp2_C	MARK1 MARK3 MARK4	1.44e-05	7	141	3	IPR028375
Domain	UBA	MARK1 MARK3 SIK1 MARK4 BRSK1	1.96e-05	44	141	5	IPR015940
Domain	UBA	MARK1 MARK3 SIK1 MARK4 BRSK1	2.71e-05	47	141	5	PS50030
Domain	Rho_GTPase_activation_prot	PLXNA3 ARHGAP24 ARHGAP22 ARHGAP4 DLC1 RALBP1	5.42e-05	88	141	6	IPR008936
Domain	SNO	SBNO2 SBNO1	5.66e-05	2	141	2	IPR026741
Domain	SBNO_Helicase_C_dom	SBNO2 SBNO1	5.66e-05	2	141	2	IPR026937
Domain	Helicase_C_4	SBNO2 SBNO1	5.66e-05	2	141	2	PF13871
Domain	Filaggrin	FLG FLG2	5.66e-05	2	141	2	IPR003303
Domain	UBA	MARK1 MARK3 SIK1 MARK4	7.32e-05	30	141	4	SM00165
Domain	RhoGAP	ARHGAP24 ARHGAP22 ARHGAP4 DLC1 RALBP1	1.05e-04	62	141	5	SM00324
Domain	RhoGAP	ARHGAP24 ARHGAP22 ARHGAP4 DLC1 RALBP1	1.13e-04	63	141	5	PF00620
Domain	RhoGAP_dom	ARHGAP24 ARHGAP22 ARHGAP4 DLC1 RALBP1	1.22e-04	64	141	5	IPR000198
Domain	RHOGAP	ARHGAP24 ARHGAP22 ARHGAP4 DLC1 RALBP1	1.22e-04	64	141	5	PS50238
Domain	-	ARHGAP24 ARHGAP22 ARHGAP4 DLC1 RALBP1	1.22e-04	64	141	5	1.10.555.10
Domain	Ca/CaM-dep_Ca-dep_prot_Kinase	MARK1 MARK3 SIK1 MARK4 BRSK1	1.74e-04	69	141	5	IPR020636
Domain	Prot_kinase_dom	ERBB2 NPR1 MARK1 CDK12 MARK3 SIK1 CDK13 MARK4 FES MAP3K13 BRSK1 FYN	3.41e-04	489	141	12	IPR000719
Domain	PROTEIN_KINASE_DOM	ERBB2 NPR1 MARK1 CDK12 MARK3 SIK1 CDK13 MARK4 FES MAP3K13 BRSK1 FYN	3.67e-04	493	141	12	PS50011
Domain	Protein_kinase_ATP_BS	ERBB2 MARK1 CDK12 MARK3 SIK1 CDK13 MARK4 FES BRSK1 FYN	6.16e-04	379	141	10	IPR017441
Domain	PROTEIN_KINASE_ATP	ERBB2 MARK1 CDK12 MARK3 SIK1 CDK13 MARK4 FES MAP3K13 BRSK1 FYN	7.34e-04	459	141	11	PS00107
Domain	Keratin_2_head	KRT6A KRT6B KRT6C	7.59e-04	24	141	3	IPR032444
Domain	Keratin_2_head	KRT6A KRT6B KRT6C	7.59e-04	24	141	3	PF16208
Domain	Kinase-like_dom	ERBB2 NPR1 MARK1 CDK12 MARK3 SIK1 CDK13 MARK4 FES MAP3K13 BRSK1 FYN	8.46e-04	542	141	12	IPR011009
Domain	Keratin_II	KRT6A KRT6B KRT6C	9.64e-04	26	141	3	IPR003054
Domain	S100_CABP	FLG HRNR FLG2	1.08e-03	27	141	3	PS00303
Domain	S_100	FLG HRNR FLG2	1.08e-03	27	141	3	PF01023
Domain	S100_Ca-bd_sub	FLG HRNR FLG2	1.20e-03	28	141	3	IPR013787
Domain	S100/CaBP-9k_CS	FLG HRNR FLG2	1.20e-03	28	141	3	IPR001751
Domain	S_100	FLG HRNR FLG2	1.20e-03	28	141	3	SM01394
Domain	DH_1	ARHGEF38 ARHGEF17 PLEKHG1 ARHGEF40	1.31e-03	63	141	4	PS00741
Domain	RhoGEF	ARHGEF38 ARHGEF17 PLEKHG1 ARHGEF40	1.94e-03	70	141	4	PF00621
Domain	DH_2	ARHGEF38 ARHGEF17 PLEKHG1 ARHGEF40	1.94e-03	70	141	4	PS50010
Domain	-	ARHGEF38 ARHGEF17 PLEKHG1 ARHGEF40	2.04e-03	71	141	4	1.20.900.10
Domain	DH-domain	ARHGEF38 ARHGEF17 PLEKHG1 ARHGEF40	2.04e-03	71	141	4	IPR000219
Domain	UBA	MARK1 MARK3 MARK4	2.51e-03	36	141	3	PF00627
Domain	Pkinase_Tyr	ERBB2 NPR1 FES MAP3K13 FYN	2.97e-03	129	141	5	PF07714
Domain	Ser-Thr/Tyr_kinase_cat_dom	ERBB2 NPR1 FES MAP3K13 FYN	3.97e-03	138	141	5	IPR001245
Domain	Dynein_heavy_chain_D4_dom	DYNC2H1 DNAH7	4.85e-03	14	141	2	IPR024317
Domain	Dynein_HC_stalk	DYNC2H1 DNAH7	4.85e-03	14	141	2	IPR024743
Domain	Dynein_heavy_dom-2	DYNC2H1 DNAH7	4.85e-03	14	141	2	IPR013602
Domain	DHC_N2	DYNC2H1 DNAH7	4.85e-03	14	141	2	PF08393
Domain	MT	DYNC2H1 DNAH7	4.85e-03	14	141	2	PF12777
Domain	AAA_8	DYNC2H1 DNAH7	4.85e-03	14	141	2	PF12780
Domain	FERM_M	FRMPD2 FRMD8 FRMD1	5.04e-03	46	141	3	PF00373
Domain	PH_dom-like	ARHGAP24 FRMPD2 TRIOBP ARHGEF17 FRMD1 PLEKHG1 ARHGAP22 ARHGEF40 IRS2	5.10e-03	426	141	9	IPR011993
Domain	DHC_fam	DYNC2H1 DNAH7	5.57e-03	15	141	2	IPR026983
Domain	Dynein_heavy	DYNC2H1 DNAH7	5.57e-03	15	141	2	PF03028
Domain	Dynein_heavy_dom	DYNC2H1 DNAH7	5.57e-03	15	141	2	IPR004273
Domain	Ser/Thr_kinase_AS	MARK1 CDK12 MARK3 SIK1 CDK13 MARK4 MAP3K13 BRSK1	5.78e-03	357	141	8	IPR008271
Domain	S_TKc	MARK1 CDK12 MARK3 SIK1 CDK13 MARK4 MAP3K13 BRSK1	5.98e-03	359	141	8	SM00220
Domain	-	FRMPD2 FRMD8 FRMD1	6.02e-03	49	141	3	1.20.80.10
Domain	FERM_central	FRMPD2 FRMD8 FRMD1	6.02e-03	49	141	3	IPR019748
Domain	FERM_domain	FRMPD2 FRMD8 FRMD1	6.02e-03	49	141	3	IPR000299
Domain	PROTEIN_KINASE_ST	MARK1 CDK12 MARK3 SIK1 CDK13 MARK4 MAP3K13 BRSK1	6.27e-03	362	141	8	PS00108
Domain	FERM/acyl-CoA-bd_prot_3-hlx	FRMPD2 FRMD8 FRMD1	6.37e-03	50	141	3	IPR014352
Domain	FERM_1	FRMPD2 FRMD8 FRMD1	6.37e-03	50	141	3	PS00660
Domain	FERM_2	FRMPD2 FRMD8 FRMD1	6.37e-03	50	141	3	PS00661
Domain	FERM_3	FRMPD2 FRMD8 FRMD1	6.37e-03	50	141	3	PS50057
Domain	Band_41_domain	FRMPD2 FRMD8 FRMD1	6.37e-03	50	141	3	IPR019749
Domain	B41	FRMPD2 FRMD8 FRMD1	6.37e-03	50	141	3	SM00295
Pathway	REACTOME_CDC42_GTPASE_CYCLE	ARHGAP24 PLEKHG1 ARHGAP22 ARHGAP4 DLC1 RALBP1	7.47e-05	94	106	6	MM15598
Pathway	REACTOME_SEMAPHORIN_INTERACTIONS	PLXNA3 ERBB2 MYH10 FES FYN	1.17e-04	64	106	5	M7923
Pathway	REACTOME_RHOA_GTPASE_CYCLE	ARHGAP24 ARHGEF17 ARHGAP22 ARHGAP4 ARHGEF40 DLC1 TJP2	1.30e-04	149	106	7	M41805
Pathway	REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION	PLXNA3 FES FYN	1.42e-04	14	106	3	MM15029
Pathway	REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION	PLXNA3 FES FYN	1.42e-04	14	106	3	M7578
Pathway	REACTOME_CRMPS_IN_SEMA3A_SIGNALING	PLXNA3 FES FYN	1.76e-04	15	106	3	MM15031
Pathway	REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION	PLXNA3 FES FYN	2.16e-04	16	106	3	M16498
Pathway	REACTOME_CRMPS_IN_SEMA3A_SIGNALING	PLXNA3 FES FYN	2.16e-04	16	106	3	M8245
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TRAF7 PLXNA3 ERBB2 CDK12 POLG FRMD8 MCM5 ELAC2 SBNO2 CABLES1 PPP1R26 PLEKHG1 ARHGEF40 MROH1 KLF10 CELSR3 ADAMTS7 CDK13 BTBD7 MARK4 ZFYVE26 IRS2 HERC1 ESPL1 IQCE PCNT BAHCC1	2.72e-13	1105	150	27	35748872
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	JCAD ERBB2 STIM2 TRA2B MARK3 PRR5 SIK1 TAB2 ARHGEF17 DNAH7 PLEKHG1 DLC1 NDRG1 MARK4 PKP2 TJP2 KMT2A IRS2 TAB1 CCSER1	1.06e-09	861	150	20	36931259
Pubmed	CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.	FLG KRT6A KRT6B MYH10 GATAD2A TRA2B DHX38 MCM5 GPATCH4 HRNR FLG2 SART1 WDR3 DDX50 KRT6C KMT2A ALYREF	1.25e-09	605	150	17	28977666
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	TRAF7 STIM2 GATAD2A MARK1 CDK12 MARK3 SIK1 CABLES1 ARHGEF40 CDK13 RALBP1 PDE4DIP AUTS2 KMT2A TAB1 MAP3K13 BRSK1 ESPL1 FYN RNF111	2.72e-09	910	150	20	36736316
Pubmed	SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling.	FLG KRT6A KRT6B TRA2B DHX38 MCM5 TAB2 HRNR FLG2 SART1 PDE4DIP ALYREF TAB1 MGA PRRC2A CCSER1	2.95e-09	558	150	16	27591049
Pubmed	Genetic variants in pachyonychia congenita-associated keratins increase susceptibility to tooth decay.	KRT6A KRT6B KRT6C	7.86e-08	3	150	3	29357356
Pubmed	Cloning and characterization of multiple human genes and cDNAs encoding highly related type II keratin 6 isoforms.	KRT6A KRT6B KRT6C	7.86e-08	3	150	3	7543104
Pubmed	Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin.	FLG HRNR FLG2	7.86e-08	3	150	3	23403047
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	ARHGAP24 GATAD2A MCM5 ARHGEF17 PLEKHG1 ARHGAP22 ARHGAP4 ARHGEF40 DLC1 DDX50 RALBP1 PKP2 TJP2 KMT2A LSM11 TAB1 MGA PRRC2A	9.67e-08	916	150	18	32203420
Pubmed	14-3-3 cooperates with LKB1 to regulate the activity and localization of QSK and SIK.	MARK1 MARK3 SIK1 MARK4 BRSK1	1.82e-07	30	150	5	16306228
Pubmed	STK11 is required for the normal program of ciliated cell differentiation in airways.	MARK1 MARK3 SIK1 MARK4 BRSK1	2.17e-07	31	150	5	31636950
Pubmed	Keratin 6 regulates collective keratinocyte migration by altering cell-cell and cell-matrix adhesion.	KRT6A KRT6B MYH10	3.14e-07	4	150	3	30389720
Pubmed	Prediction of the coding sequences of unidentified human genes. XVII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	JCAD STIM2 MARK1 HCN3 PHRF1 BTBD7 BAHCC1	3.38e-07	103	150	7	10819331
Pubmed	LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1.	MARK1 SIK1 MARK4 BRSK1	4.37e-07	15	150	4	14976552
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	TRA2B CDK12 TOGARAM1 SART1 CELSR3 DDX50 CDK13 TJP2 IRS2 PRRC2A CPSF7	5.33e-07	361	150	11	26167880
Pubmed	MARK4 is a novel microtubule-associated proteins/microtubule affinity-regulating kinase that binds to the cellular microtubule network and to centrosomes.	MYH10 MARK1 MARK3 MARK4	5.81e-07	16	150	4	14594945
Pubmed	Pachyonychia Congenita	KRT6A KRT6B KRT6C	7.81e-07	5	150	3	20301457
Pubmed	Roles of tau protein in health and disease.	MARK1 MARK3 MARK4 BRSK1 FYN	8.13e-07	40	150	5	28386764
Pubmed	Role of individual MARK isoforms in phosphorylation of tau at Ser²⁶² in Alzheimer's disease.	MARK1 MARK3 MARK4	1.56e-06	6	150	3	23666762
Pubmed	Phosphorylation of microtubule-associated protein tau by AMPK-related kinases.	MARK1 SIK1 BRSK1	1.56e-06	6	150	3	21985311
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	TRAF7 ERBB2 GATAD2A FAT3 PHRF1 KIAA1549 GPATCH4 SART1 ARHGAP4 ZNF469 ARHGEF40 MARK4 PKP2 HRES1 IRS2 KIF18B MGA BAHCC1	1.68e-06	1116	150	18	31753913
Pubmed	Mouse cartilage matrix deficiency (cmd) caused by a 7 bp deletion in the aggrecan gene.	ZP2 FES GABRA4	2.72e-06	7	150	3	7920633
Pubmed	Frizzled6 deficiency disrupts the differentiation process of nail development.	KRT6A KRT6B HRNR	2.72e-06	7	150	3	23439395
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ERBB2 CDK12 PHRF1 TRIOBP KIAA1549 SRCIN1 KIAA1614 ARHGAP4 CELSR3 AUTS2 ESPL1 IQCE	3.50e-06	529	150	12	14621295
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	JCAD TMEM201 MYH10 DYNC2I1 MCM5 TAB2 DNAH7 WDR3 PLEKHG1 NDRG1 MEIOC TJP2 TAB1 MGA PCNT	4.67e-06	853	150	15	28718761
Pubmed	Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer.	MARK1 MARK3 ARHGEF17 PKP2 TJP2 IRS2	5.57e-06	102	150	6	15778465
Pubmed	The p300/YY1/miR-500a-5p/HDAC2 signalling axis regulates cell proliferation in human colorectal cancer.	KRT6A KRT6B MYH10 GATAD2A MCM5 HRNR ELAC2 TAB1 CPSF7	6.37e-06	298	150	9	30737378
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	CACNB2 ERBB2 MYH10 MARK3 POLG FRMPD2 PRR5 ARHGEF38 TRIOBP DYNC2I1 SRCIN1 SBNO2 ANKRD44 NDRG1 CDK13 PKD2 AUTS2 KATNIP PCNT FAM149A	6.79e-06	1489	150	20	28611215
Pubmed	Stage- and subunit-specific functions of polycomb repressive complex 2 in bladder urothelial formation and regeneration.	KRT6A KRT6B MYH10 SMTN	7.26e-06	29	150	4	28049658
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	KRT6A ERBB2 STIM2 MYH10 TRA2B CAMLG POLG DYNC2I1 GPATCH4 FLG2 ELAC2 WDR3 DDX50 CDK13 ALYREF TAB1 HERC1 ESPL1 PCNT CPSF7	7.27e-06	1496	150	20	32877691
Pubmed	Prediction of the coding sequences of unidentified human genes. XX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	ZNF469 KRBA1 MROH1 CDK13 MARK4 BRSK1	7.35e-06	107	150	6	11347906
Pubmed	Suppression of DDX39B sensitizes ovarian cancer cells to DNA-damaging chemotherapeutic agents via destabilizing BRCA1 mRNA.	KRT6A KRT6B HRNR FLG2 KRT6C ALYREF	7.35e-06	107	150	6	32989256
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	STIM2 ABCC5 GPATCH4 HRNR FLG2 DNAH7 ANKRD46 SART1 WDR3 DDX50 PKP2 TJP2 MGA IQCE	7.49e-06	777	150	14	35844135
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	KRT6A MYH10 RBMXL3 GATAD2A CDK12 MARK3 NUTM2A GPATCH4 FLG2 WDR3 ARHGEF40 CDK13 RALBP1 PKP2 TJP2 KMT2A ALYREF PRRC2A CPSF7	7.59e-06	1371	150	19	36244648
Pubmed	PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation.	TRA2B CDK12 MARK3 PRR5 GPATCH4 SART1 WDR3 DDX50 CDK13 PKP2 ALYREF TAB1 PRRC2A	8.34e-06	678	150	13	30209976
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	KRT6A KRT6B MYH10 GATAD2A TRA2B MARK3 DHX38 MCM5 HRNR FLG2 WTAP SART1 WDR3 DDX50 PKP2 TJP2 ALYREF CPSF7	8.65e-06	1257	150	18	36526897
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	STIM2 DYNC2H1 MARK1 DHX38 TOGARAM1 PPP1R26 ZBTB34 KRBA1 CDK13 MGA CCSER1	1.05e-05	493	150	11	15368895
Pubmed	Functional proteomics mapping of a human signaling pathway.	NPR1 STIM2 MYH10 CDK12 PPP1R26 KLF10 CDK13 PDE4DIP PKP2 HERC1 MGA RNF111	1.07e-05	591	150	12	15231748
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MYH10 MARK3 ARHGEF17 PLEKHG1 MROH1 BTBD7 MARK4 PDE4DIP KATNIP PCNT	1.18e-05	407	150	10	12693553
Pubmed	SARS-CoV-2 N Protein Antagonizes Stress Granule Assembly and IFN Production by Interacting with G3BPs to Facilitate Viral Replication.	FLG KRT6A KRT6B HRNR FLG2 DDX50 TAB1 HERC1	1.20e-05	245	150	8	35652658
Pubmed	Atypical E2F repressors and activators coordinate placental development.	PDGFB MCM5 NDRG1 ESPL1	1.23e-05	33	150	4	22516201
Pubmed	A unique form of collective epithelial migration is crucial for tissue fusion in the secondary palate and can overcome loss of epithelial apoptosis.	KRT6A KRT6B MYH10	1.26e-05	11	150	3	35593401
Pubmed	CDK12 and HER2 coamplification in two urothelial carcinomas with rapid and aggressive clinical progression.	ERBB2 CDK12	1.85e-05	2	150	2	33038052
Pubmed	Expression of MK6a dominant-negative and C-terminal mutant transgenes in mice has distinct phenotypic consequences in the epidermis and hair follicle.	KRT6A KRT6B	1.85e-05	2	150	2	10550543
Pubmed	The mouse keratin 6 isoforms are differentially expressed in the hair follicle, footpad, tongue and activated epidermis.	KRT6A KRT6B	1.85e-05	2	150	2	10550545
Pubmed	Human CDK12 and CDK13, multi-tasking CTD kinases for the new millenium.	CDK12 CDK13	1.85e-05	2	150	2	30319007
Pubmed	ERBB2-amplified lobular breast carcinoma exhibits concomitant CDK12 co-amplification associated with poor prognostic features.	ERBB2 CDK12	1.85e-05	2	150	2	38335502
Pubmed	The two functional keratin 6 genes of mouse are differentially regulated and evolved independently from their human orthologs.	KRT6A KRT6B	1.85e-05	2	150	2	9790766
Pubmed	Activated macrophage survival is coordinated by TAK1 binding proteins.	TAB2 TAB1	1.85e-05	2	150	2	24736749
Pubmed	Cdk12 and Cdk13 regulate axonal elongation through a common signaling pathway that modulates Cdk5 expression.	CDK12 CDK13	1.85e-05	2	150	2	24999027
Pubmed	Discovery of a novel murine keratin 6 (K6) isoform explains the absence of hair and nail defects in mice deficient for K6a and K6b.	KRT6A KRT6B	1.85e-05	2	150	2	11489919
Pubmed	Bid is cleaved upstream of caspase-8 activation during TRAIL-mediated apoptosis in human osteosarcoma cells.	TNFSF10 BID	1.85e-05	2	150	2	17431792
Pubmed	Introducing a null mutation in the mouse K6alpha and K6beta genes reveals their essential structural role in the oral mucosa.	KRT6A KRT6B	1.85e-05	2	150	2	10953016
Pubmed	The complete cDNA and deduced amino acid sequence of a type II mouse epidermal keratin of 60,000 Da: analysis of sequence differences between type I and type II keratins.	KRT6A KRT6B	1.85e-05	2	150	2	6207530
Pubmed	Cross interference with TNF-alpha-induced TAK1 activation via EGFR-mediated p38 phosphorylation of TAK1-binding protein 1.	TAB2 TAB1	1.85e-05	2	150	2	19393267
Pubmed	Myosin II is a negative regulator of oligodendrocyte morphological differentiation.	MYH10 FYN	1.85e-05	2	150	2	22437915
Pubmed	CDK12 is a transcription elongation-associated CTD kinase, the metazoan ortholog of yeast Ctk1.	CDK12 CDK13	1.85e-05	2	150	2	20952539
Pubmed	Dynamic transcriptional changes of TIEG1 and TIEG2 during mouse tissue development.	KLF11 KLF10	1.85e-05	2	150	2	20201061
Pubmed	Klf10 deficiency in mice exacerbates pulmonary inflammation by increasing expression of the proinflammatory molecule NPRA.	NPR1 KLF10	1.85e-05	2	150	2	27592451
Pubmed	Kendrin is a novel substrate for separase involved in the licensing of centriole duplication.	ESPL1 PCNT	1.85e-05	2	150	2	22542101
Pubmed	Molecular cloning and characterization of TIEG2 reveals a new subfamily of transforming growth factor-beta-inducible Sp1-like zinc finger-encoding genes involved in the regulation of cell growth.	KLF11 KLF10	1.85e-05	2	150	2	9748269
Pubmed	A reporter transgene based on a human keratin 6 gene promoter is specifically expressed in the periderm of mouse embryos.	KRT6A KRT6B	1.85e-05	2	150	2	11118885
Pubmed	Study of Strawberry Notch homolog 1 and 2 expression in human glioblastoma.	SBNO2 SBNO1	1.85e-05	2	150	2	36695974
Pubmed	Atopic Dermatitis Susceptibility Variants in Filaggrin Hitchhike Hornerin Selective Sweep.	FLG HRNR	1.85e-05	2	150	2	27678121
Pubmed	Transcriptional profiling of pure fibrolamellar hepatocellular carcinoma reveals an endocrine signature.	PCSK1 ERBB2	1.85e-05	2	150	2	24443104
Pubmed	Characterization of human cyclin-dependent kinase 12 (CDK12) and CDK13 complexes in C-terminal domain phosphorylation, gene transcription, and RNA processing.	CDK12 CDK13	1.85e-05	2	150	2	25561469
Pubmed	Deficiency of GMDS leads to escape from NK cell-mediated tumor surveillance through modulation of TRAIL signaling.	TNFSF10 GMDS	1.85e-05	2	150	2	19361506
Pubmed	Identification of a Src kinase SH3 binding site in the C-terminal domain of the human ErbB2 receptor tyrosine kinase.	ERBB2 FYN	1.85e-05	2	150	2	24815698
Pubmed	Collapse of the keratin filament network through the expression of mutant keratin 6c observed in a case of focal plantar keratoderma.	KRT6A KRT6C	1.85e-05	2	150	2	23662636
Pubmed	Bid mediates apoptotic synergy between tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and DNA damage.	TNFSF10 BID	1.85e-05	2	150	2	15615731
Pubmed	Dual Inhibition of CDK12/CDK13 Targets Both Tumor and Immune Cells in Ovarian Cancer.	CDK12 CDK13	1.85e-05	2	150	2	35857807
Pubmed	Delayed wound healing in keratin 6a knockout mice.	KRT6A KRT6B	1.85e-05	2	150	2	10866680
Pubmed	New mutations in DYNC2H1 and WDR60 genes revealed by whole-exome sequencing in two unrelated Sardinian families with Jeune asphyxiating thoracic dystrophy.	DYNC2H1 DYNC2I1	1.85e-05	2	150	2	26874042
Pubmed	Cytokeratins mediate epithelial innate defense through their antimicrobial properties.	KRT6A KRT6B	1.85e-05	2	150	2	23006328
Pubmed	N-myc downstream-regulated gene 1 is involved in the regulation of cystogenesis in transgenic mice overexpressing human PKD2 gene.	NDRG1 PKD2	1.85e-05	2	150	2	23212942
Pubmed	The novel dithiocarbamate, DpdtC suppresses HER2-overexpressed cancer cells by up-regulating NDRG1 via inactivation of HER2-ERK 1/2 signaling.	ERBB2 NDRG1	1.85e-05	2	150	2	29467385
Pubmed	Expression of filaggrin-2 protein in the epidermis of human skin diseases: a comparative analysis with filaggrin.	FLG FLG2	1.85e-05	2	150	2	24813994
Pubmed	Platelet Derived Growth Factor-B and Human Epidermal Growth Factor Receptor-2 Polymorphisms in Gall Bladder Cancer.	ERBB2 PDGFB	1.85e-05	2	150	2	26320430
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CACNB2 MYH10 ARHGAP24 TRA2B HCN3 TRIOBP GRM2 SART1 CCDC13 PDE4DIP ALYREF BRSK1 MGA PRRC2A PCNT	1.95e-05	963	150	15	28671696
Pubmed	Plexin signaling via off-track and rho family GTPases.	PLXNA3 FES FYN	2.18e-05	13	150	3	11604131
Pubmed	Proteomics analysis of protein kinases by target class-selective prefractionation and tandem mass spectrometry.	MARK1 CDK12 MARK3 MARK4 FYN	2.29e-05	78	150	5	17192257
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	KRT6B TMEM201 MYH10 GATAD2A TRA2B DHX38 MCM5 GPATCH4 ELAC2 SMTN SART1 WDR3 ARHGEF40 DDX50 PKP2 ALYREF KIF18B MGA	2.31e-05	1353	150	18	29467282
Pubmed	Targeted and Interactome Proteomics Revealed the Role of PHD2 in Regulating BRD4 Proline Hydroxylation.	MYH10 TRA2B MCM5 SART1 DDX50 ALYREF TAB1 MGA PRRC2A CPSF7	2.34e-05	441	150	10	31239290
Pubmed	Ephrin-As, Eph receptors and integrin α3 interact and colocalise at membrane protrusions of U251MG glioblastoma cells.	KRT6A KRT6B TOGARAM1 HRNR ARHGEF17 KRT6C PDE4DIP	2.50e-05	197	150	7	23686814
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	JCAD MARK1 MARK3 KIAA1549 ANKRD44 PLEKHG1 PKP2 TJP2 IRS2 TAB1	2.58e-05	446	150	10	24255178
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	TICRR GATAD2A CDK12 MARK3 GPATCH4 WTAP SART1 WDR3 DDX50 CDK13 ALYREF ESPL1 PRRC2A	2.72e-05	759	150	13	35915203
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	KRT6A MYH10 TRIOBP SART1 GSDMD TJP2 PRRC2A PCNT CPSF7	2.85e-05	360	150	9	33111431
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	MYH10 GATAD2A CDK12 DHX38 SART1 DDX50 ALYREF MGA	3.38e-05	283	150	8	30585729
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	KRT6A GATAD2A TRA2B MCM5 HRNR SART1 WDR3 DDX50 KRT6C TJP2 ALYREF MGA FYN PCNT CPSF7	3.94e-05	1024	150	15	24711643
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	JCAD PDE7A CAMLG POLG TRIOBP DYNC2I1 ABCC5 WDR3 CCDC13 NDRG1 CELSR3 SBNO1 RALBP1 PDE4DIP PRRC2A RNF111 PCNT	4.24e-05	1285	150	17	35914814
Pubmed	The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer.	MYH10 CDK12 TRIOBP ALYREF LSM11 PRRC2A	4.46e-05	147	150	6	28977470
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	TICRR TMEM201 GATAD2A TRA2B DHX38 PHRF1 GPATCH4 WTAP SART1 WDR3 DDX50 CDK13 KMT2A ALYREF KIF18B MGA CPSF7	4.62e-05	1294	150	17	30804502
Pubmed	TRIM25 and DEAD-Box RNA Helicase DDX3X Cooperate to Regulate RIG-I-Mediated Antiviral Immunity.	FLG KRT6A KRT6B HRNR FLG2	4.82e-05	91	150	5	34445801
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	PLXNA3 FLG KRT6A KRT6B STIM2 MYH10 ABCC5 SIK1 MCM5 SART1 DDX50 KRT6C SBNO1 CDK13 KMT2A SPAG17 PCNT BAHCC1	5.28e-05	1442	150	18	35575683
Pubmed	Identification and characterization of ARHGAP24 and ARHGAP25 genes in silico.	ARHGAP24 ARHGAP22	5.53e-05	3	150	2	15254788
Pubmed	Overcoming functional redundancy to elicit pachyonychia congenita-like nail lesions in transgenic mice.	KRT6A KRT6B	5.53e-05	3	150	2	15601842
Pubmed	Cytokeratin 5/6 expression in bladder cancer: association with clinicopathologic parameters and prognosis.	KRT6A KRT6B	5.53e-05	3	150	2	29587848
Pubmed	FRMD8 targets both CDK4 activation and RB degradation to suppress colon cancer growth.	FRMD8 FRMD8P1	5.53e-05	3	150	2	37527040
Pubmed	Epithelial transforming growth factor β-activated kinase 1 (TAK1) is activated through two independent mechanisms and regulates reactive oxygen species.	TAB2 TAB1	5.53e-05	3	150	2	22331902
Pubmed	Pharmacogenetics of ABCB5, ABCC5 and RLIP76 and doxorubicin pharmacokinetics in Asian breast cancer patients.	ABCC5 RALBP1	5.53e-05	3	150	2	26975227
Interaction	TOP3B interactions	TRAF7 PLXNA3 ERBB2 MYH10 CDK12 POLG FRMD8 MCM5 ELAC2 SBNO2 CABLES1 PPP1R26 PLEKHG1 ARHGEF40 MROH1 KLF10 CELSR3 ADAMTS7 CDK13 BTBD7 MARK4 PKP2 ZFYVE26 IRS2 HERC1 ESPL1 PRRC2A IQCE PCNT BAHCC1	1.62e-07	1470	145	30	int:TOP3B
Interaction	CHD3 interactions	KRT6A KRT6B MYH10 GATAD2A TRA2B DHX38 MCM5 GPATCH4 HRNR FLG2 BID SART1 WDR3 DDX50 KRT6C SBNO1 KMT2A ALYREF PCNT	2.18e-06	757	145	19	int:CHD3
Interaction	YWHAZ interactions	JCAD TICRR KLF11 KRT6B ERBB2 STIM2 MYH10 PDE7A TRA2B MARK1 MARK3 PRR5 SIK1 TAB2 HRNR WTAP MARK4 PKP2 TJP2 KMT2A KATNIP IRS2 TAB1 PRRC2A PCNT CCSER1	2.39e-06	1319	145	26	int:YWHAZ
Interaction	YWHAE interactions	JCAD TICRR STIM2 MYH10 PDE7A TRA2B MARK1 CDK12 MARK3 PRR5 SIK1 TAB2 SRCIN1 WTAP CDK13 MARK4 PKP2 TJP2 KMT2A IRS2 TAB1 BRSK1 MGA PRRC2A CCSER1	3.25e-06	1256	145	25	int:YWHAE
Interaction	YWHAG interactions	JCAD TICRR STIM2 MYH10 TRA2B MARK1 CDK12 MARK3 PRR5 SIK1 MCM5 TAB2 ARHGEF17 DNAH7 PLEKHG1 DLC1 NDRG1 MARK4 PKP2 TJP2 KMT2A IRS2 TAB1 CCSER1	9.39e-06	1248	145	24	int:YWHAG
Interaction	YWHAH interactions	JCAD TICRR STIM2 MARK1 MARK3 DHX38 PRR5 SIK1 TAB2 ARHGEF17 DNAH7 PLEKHG1 NDRG1 MARK4 PKP2 TJP2 KMT2A IRS2 TAB1 HERC1 PCNT CCSER1	1.31e-05	1102	145	22	int:YWHAH
Interaction	CYLD interactions	TRAF7 FLG KRT6A KRT6B MYH10 TRA2B DHX38 MCM5 TAB2 HRNR FLG2 SART1 PDE4DIP ALYREF TAB1 MGA PRRC2A CCSER1	5.30e-05	868	145	18	int:CYLD
Cytoband	8q22.2	LRP12 ANKRD46 KLF10	5.77e-05	23	150	3	8q22.2
Cytoband	4q22.1	ARHGAP24 PKD2 CCSER1	8.41e-05	26	150	3	4q22.1
Cytoband	22q13.1	PDGFB TRIOBP MCM5 TAB1	1.80e-04	85	150	4	22q13.1
Cytoband	10q11.22	FRMPD2 GDF2 ARHGAP22	3.33e-04	41	150	3	10q11.22
GeneFamily	EF-hand domain containing\|S100 fused type protein family	FLG HRNR FLG2	4.69e-06	7	94	3	1350
GeneFamily	Rho GTPase activating proteins\|BCH domain containing	ARHGAP24 ARHGAP22 ARHGAP4 DLC1	1.31e-04	50	94	4	721
GeneFamily	Keratins, type II	KRT6A KRT6B KRT6C	3.64e-04	27	94	3	609
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ARHGEF38 ARHGEF17 PLEKHG1 ARHGEF40	3.86e-04	66	94	4	722
GeneFamily	Ankyrin repeat domain containing\|FERM domain containing	FRMPD2 FRMD8 FRMD1	2.24e-03	50	94	3	1293
Coexpression	PEREZ_TP53_TARGETS	FLG ILDR2 CACNB2 PHRF1 KIAA1549 ABCC5 FRMD8 ARHGEF17 GALR2 BID ANKRD46 ZBTB34 KRBA1 ARHGEF40 MEIOC ADAMTS7 LOXL1 MARK4 AUTS2 FYN GABRA4 FAM149A	1.11e-06	1201	148	22	M4391
Coexpression	HE_LIM_SUN_FETAL_LUNG_C1_EARLY_STALK_CELL	ILDR2 TICRR PDE7A FAT3 IGDCC3 ARHGAP22 ADAMTS7 LOXL1 ST8SIA2 ALYREF CFAP119 KIF18B ESPL1 C6orf141	4.34e-06	567	148	14	M45692
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	PLXNA3 LRP12 STIM2 ARHGAP24 PDE7A MARK1 HCN3 NUTM2A KIAA1549 ABCC5 SRCIN1 ANKRD44 CELSR3 PDE4DIP ST8SIA2 AUTS2 LSM11 HERC1 SPAG17 CCSER1	4.36e-06	1106	148	20	M39071
Coexpression	AIZARANI_LIVER_C9_LSECS_1	NPR1 MYH10 PDGFB TRIOBP DYNC2I1 FRMD8 SMTN PLEKHG1 DLC1 HERC1	9.45e-06	304	148	10	M39113
Coexpression	KOYAMA_SEMA3B_TARGETS_UP	DYNC2H1 PRR5 CCDC80 SMTN PLEKHG1 DLC1 LOXL1 MARK4 PKP2	2.27e-05	268	148	9	M12746
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DYNC2H1 ARHGEF38 DNAH7 KIF19 KATNIP CFAP119 SPAG17 FAM149A	1.73e-07	180	149	8	92fb01b91261b3103454924cde56add337b41844
ToppCell	TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3\|TCGA-Lung / Sample_Type by Project: Shred V9	TICRR KRT6A KRT6B LRP12 TRA2B MARK1 ABCC5	2.93e-06	184	149	7	ea4ccebe2d54279fcc517e4f0bfa652b91a808bb
ToppCell	PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	CACNB2 MYH10 FAT3 CCDC80 DLC1 LOXL1 ST8SIA2	3.63e-06	190	149	7	1196b8ea2c44c7c80f5ee589dd517e6a413f2077
ToppCell	facs-Lung-3m\|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ABCC5 SIK1 CCDC80 DBP WTAP PKD2 IRS2	4.30e-06	195	149	7	c4648c0332c3826776f9ad3f5f803dbac2b4c0c0
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FLG ILDR2 NPR1 CCDC80 FRMD1 LOXL1 GMDS	4.45e-06	196	149	7	545d2e4469924d333e3f655f559c899fa1260196
ToppCell	NS-moderate-d_0-4-Epithelial\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ERBB2 STIM2 TNFSF10 DYNC2I1 CCDC80 TJP2 MAP3K13	5.08e-06	200	149	7	64462a18afca3c1a8548a857924b8166058bf958
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage\|356C / Donor, Lineage, Cell class and subclass (all cells)	DYNC2I1 GALR2 CCDC13 TJP2 LSM11 C6orf141	1.60e-05	159	149	6	24f87c666eff10c1844c900ffd7ad49fa9f80481
ToppCell	TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Papillary_Renal_Cell_Carcinoma-7\|TCGA-Kidney / Sample_Type by Project: Shred V9	TRIOBP CCDC13 KATNIP CFAP119 BRSK1 IQCE	2.05e-05	166	149	6	b545de32578047c9ca422354b8992f2d9c9e1cc7
ToppCell	Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)\|Thalamus / BrainAtlas - Mouse McCarroll V32	ILDR2 PLEKHG1 AUTS2 PKP2 GABRA4	2.18e-05	100	149	5	20675fc2ffc5ab63047d38da083b50d470f3db19
ToppCell	Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6\|Thalamus / BrainAtlas - Mouse McCarroll V32	ILDR2 PLEKHG1 AUTS2 PKP2 GABRA4	2.18e-05	100	149	5	1de3895e16f14ff32b901b18ce14d965afaa7e76
ToppCell	Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Rora\|Thalamus / BrainAtlas - Mouse McCarroll V32	ILDR2 PLEKHG1 AUTS2 PKP2 GABRA4	2.18e-05	100	149	5	ff1bdb511700a041a90034d1d30dfc25f51d6c82
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DYNC2H1 DYNC2I1 DNAH7 CCDC13 CFAP119 SPAG17	2.26e-05	169	149	6	fba841664939c771881ba97f14ef1df6635c04ff
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231\|Adult / Lineage, Cell type, age group and donor	ARHGEF38 PLEKHG1 AUTS2 MAP3K13 FAM149A CCSER1	2.34e-05	170	149	6	269dee5abca9f6aa079f116f0d8f1d198604d9d4
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ILDR2 MARK1 CABLES1 PPP1R26 CELSR3 BRSK1	3.22e-05	180	149	6	c72f15763ba707189e29c85db533557f01c7fdb1
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DYNC2H1 DYNC2I1 CCDC80 DNAH7 KIF19 SPAG17	3.22e-05	180	149	6	1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	STIM2 PRR5 KIAA1614 DDX50 KMT2A FYN	3.33e-05	181	149	6	986c036e656f24fe374807e2711cec9e3c83c892
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FRMPD2 DNAH7 CCDC13 KIF19 CFAP119 SPAG17	3.33e-05	181	149	6	dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6
ToppCell	E18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_A\|E18.5-samps / Age Group, Lineage, Cell class and subclass	ILDR2 JCAD PDGFB GSDMD KIF18B ESPL1	3.43e-05	182	149	6	ea4f6c8f600ffe9f8e0609637b3371a5ac48ca03
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ARHGEF38 PLEKHG1 TMEM132D AUTS2 MAP3K13 FAM149A	3.76e-05	185	149	6	98b8ee42b89d97e4c9db01740e0c193503c68f2c
ToppCell	NS-moderate-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DYNC2H1 FRMPD2 DNAH7 CCDC13 KIF19 SPAG17	3.76e-05	185	149	6	5e689c2fb36ce3ac2adc8d15f67107f21cf68868
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	CACNB2 PDE7A PDE4DIP PKP2 GABRA4 CCSER1	3.76e-05	185	149	6	6baccb26f999145e51b91d94315bf8d4655bef31
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KRT6A KRT6B TAB2 KIAA1614 KRT6C LOXL1	3.99e-05	187	149	6	a6a112689d1c9049f57935ad9d2f4955538427de
ToppCell	droplet-Tongue-nan\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRA2B CDK12 NDRG1 KLF10 SBNO1 RALBP1	4.11e-05	188	149	6	d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd
ToppCell	PCW_13-14-Endothelial-Endothelial_mature-endo_bronchial_(8)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	NPR1 PDGFB TNFSF10 SBNO2 PLEKHG1 IL3RA	4.11e-05	188	149	6	986aaf31161ec3d1e6c76ee2dd17f44848a21f7e
ToppCell	PND07-28-samps-Mesenchymal-Matrix_fibroblast\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	CACNB2 MYH10 CCDC80 DLC1 LOXL1 ST8SIA2	4.23e-05	189	149	6	dc5164591dea45b420798b94dda211be03daa70c
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ILDR2 ARHGEF38 PLEKHG1 TMEM132D FAM149A CCSER1	4.23e-05	189	149	6	7659c7bbd58ee959a159294fb8d17317bbcc5681
ToppCell	TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma\|TCGA-Lung / Sample_Type by Project: Shred V9	TICRR KRT6A KRT6B MARK1 ABCC5 KRT6C	4.23e-05	189	149	6	aa4f7d7a5196e5ae481ebc2549de8e3f0ef6e6be
ToppCell	Monocytes-Tissue-resident_macrophages\|World / Immune cells in Kidney/Urine in Lupus Nephritis	PDGFB ARHGAP22 ARHGEF40 PKP2 IRS2 FAM149A	4.36e-05	190	149	6	07215e8f292cb54c670037aaf28393cddbe5548c
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ARHGEF38 DNAH7 PLEKHG1 TMEM132D FAM149A CCSER1	4.49e-05	191	149	6	60ff989fe99d243a3d52955223680cdd1f1917a4
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP24 ARHGEF38 DNAH7 PDE4DIP SPAG17 CCSER1	4.49e-05	191	149	6	5a67ff17fb4b9eff641176dff07830c9cd73754e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP24 ARHGEF38 DNAH7 PDE4DIP SPAG17 CCSER1	4.49e-05	191	149	6	55ab2854a02cdcfc395e49870ccb7290b5e5471d
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ARHGEF38 PLEKHG1 KIF18B ESPL1 C6orf141 CCSER1	4.62e-05	192	149	6	25378b5e4b0cea8415ff125783511fc25a56fc00
ToppCell	PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ARHGEF38 DNAH7 PLEKHG1 TMEM132D FAM149A CCSER1	4.62e-05	192	149	6	b99f8236ef4ccdc75c02abea381cae6453205f6f
ToppCell	droplet-Liver-LIVER_HEP-30m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JCAD NPR1 CCDC80 PLEKHG1 DLC1 NDRG1	4.76e-05	193	149	6	826b8dd801298b3e0cd76232feae5a14026b8806
ToppCell	Monocytes-Tissue-resident_macrophages\|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis	ARHGAP24 PDGFB ARHGAP22 PKP2 IRS2 FAM149A	4.76e-05	193	149	6	198552810dcac8d0ca63a78badd6702b49ff6edf
ToppCell	droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JCAD NPR1 CCDC80 PLEKHG1 DLC1 NDRG1	4.76e-05	193	149	6	87d3a577d37fb0cb4b6313c596310de452bc3872
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DYNC2H1 FRMPD2 DYNC2I1 DNAH7 KIF19 SPAG17	4.76e-05	193	149	6	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	PCW_10-12-Endothelial-Endothelial_cycling-endo_proliferating1_(10)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	JCAD NPR1 PDGFB TNFSF10 PLEKHG1 IL3RA	4.76e-05	193	149	6	643f992dbce639e7d147924d8b8f455fcebf215a
ToppCell	COVID-19-kidney-CD-PC\|kidney / Disease (COVID-19 only), tissue and cell type	STIM2 MYH10 ARHGEF38 NDRG1 RALBP1 CCSER1	4.76e-05	193	149	6	738689d009e4b118d7ce3171a207294b95cbe78b
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ARHGEF38 DNAH7 PLEKHG1 TMEM132D FAM149A CCSER1	4.90e-05	194	149	6	f95c8dc242c9aebcadfe61b1ed033349cb7e5a88
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DYNC2H1 DYNC2I1 DNAH7 KIF19 CFAP119 SPAG17	4.90e-05	194	149	6	4a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CCDC80 DNAH7 KIF19 CFAP119 SPAG17 IQCE	5.04e-05	195	149	6	79dc031258579ea328181dda33710dd897f1064a
ToppCell	PCW_10-12-Endothelial-Endothelial_immature-endo_immature_arterial1_(12)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	JCAD NPR1 PDGFB TNFSF10 PLEKHG1 IL3RA	5.04e-05	195	149	6	3826bfafe85f8aa9a508202ceb2b02e81b090498
ToppCell	moderate-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DYNC2H1 FRMPD2 DNAH7 KIF19 CFAP119 SPAG17	5.04e-05	195	149	6	3486eae5fdb062a75a907b896c9d7b396d2aa195
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNB2 MARK1 FAT3 KIAA1614 ADAMTS7 BRSK1	5.04e-05	195	149	6	f5e91ce20a7ce528dc4c1a968c7bf096bf45c528
ToppCell	(1)_Control_(PBS)-(1)_VE-Cad+_vascular_cells\|World / Stress and Cell class	NPR1 STIM2 SIK1 SBNO2 PLEKHG1 NDRG1	5.04e-05	195	149	6	6b5d3ecec0c00ebfc889dc6235390ff53b5c0b6a
ToppCell	PCW_13-14-Endothelial-Endothelial_mature\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	JCAD NPR1 PDGFB TNFSF10 PLEKHG1 IL3RA	5.04e-05	195	149	6	31353269591c9eee84872838e91995d4a035da46
ToppCell	PCW_10-12-Endothelial-Endothelial_immature-endo_immature1_(0)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	JCAD NPR1 PDGFB TNFSF10 PLEKHG1 IL3RA	5.18e-05	196	149	6	29ed8b1c4cd730db8632fde6eece404f1883a86d
ToppCell	PCW_10-12-Endothelial-Endothelial_immature\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	JCAD NPR1 PDGFB TNFSF10 PLEKHG1 IL3RA	5.18e-05	196	149	6	c65b8c7ea34a21897c390e6fb42ee8ca41e9c976
ToppCell	PCW_10-12-Endothelial-Endothelial_mature\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	JCAD NPR1 PDGFB TNFSF10 PLEKHG1 IL3RA	5.18e-05	196	149	6	481d79bdaec069ad2746a28d39eeee8d3edf7305
ToppCell	PCW_10-12-Endothelial-Endothelial_immature-endo_immature2_(1)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	JCAD NPR1 PDGFB TNFSF10 PLEKHG1 IL3RA	5.18e-05	196	149	6	0e8d649b50be2d707510b897bb97767b5847dff9
ToppCell	NS-control-d_0-4-Epithelial-Ciliated\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DYNC2H1 FRMPD2 DNAH7 KIF19 CFAP119 SPAG17	5.18e-05	196	149	6	d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a
ToppCell	PCW_10-12-Endothelial\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	JCAD NPR1 PDGFB TNFSF10 PLEKHG1 IL3RA	5.18e-05	196	149	6	2c60dcf9132ee156f25b349e2ac5313709def4f6
ToppCell	LV-03._Atrial_Cardiomyocyte\|LV / Chamber and Cluster_Paper	CACNB2 GRM2 PDE4DIP PRRC2A CCSER1	5.22e-05	120	149	5	3b77bd0e3630cdd45001cecf5e47660a90ebc92e
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYH10 ARHGAP24 MARK1 SMTN LOXL1 TJP2	5.33e-05	197	149	6	26475b9e4d6bfc0ae818dea13d139888ed7e92f1
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-F\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	NPR1 TRIOBP CCDC80 NDRG1 LOXL1 FYN	5.33e-05	197	149	6	fbff2fb7a8142b88c9dc71aa10980f4350b7e081
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYH10 ARHGAP24 MARK1 SMTN LOXL1 TJP2	5.33e-05	197	149	6	155e63b33302a87393ace699b2f6d73abe9c5763
ToppCell	ASK452-Endothelial-Endothelium\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	JCAD PDGFB TNFSF10 PLEKHG1 DLC1 TJP2	5.48e-05	198	149	6	e282769f5fa1765bcce79a0ed9d761bf2e14b012
ToppCell	(10)_Ciliated-(2)_GFP_FOXI1\|(10)_Ciliated / shred by cell type by condition	DYNC2I1 TOGARAM1 SBNO1 RALBP1 SPAG17 FYN	5.64e-05	199	149	6	61b1ed2db71b96157b92b7535d1955a4033098da
ToppCell	(03)_KRT6B+\|World / shred by cell type by condition	KRT6A KRT6B PDGFB SIK1 IRS2 FYN	5.64e-05	199	149	6	9feaf8649b3f68f30b8cb6b045a2caa2dd343c7f
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PDGFB TNFSF10 DLC1 KMT2A FYN PCNT	5.80e-05	200	149	6	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	Bronchus_Control_(B.)-Epithelial-TX-Ciliated\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	DYNC2H1 FRMPD2 DNAH7 KIF19 CFAP119 SPAG17	5.80e-05	200	149	6	6a2ccc71a0cbe04a542c379b28b5006de53981c3
ToppCell	Control_saline-Endothelial-Endothelial-Gen_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	NPR1 STIM2 PDGFB TNFSF10 DLC1 FYN	5.80e-05	200	149	6	3b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCell	Control_saline-Endothelial-Endothelial\|Control_saline / Treatment groups by lineage, cell group, cell type	JCAD NPR1 STIM2 PDGFB TNFSF10 DLC1	5.80e-05	200	149	6	e77eba6172cabf85b8028638ed35299f2f079cd8
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	NPR1 PDGFB TNFSF10 DLC1 FYN CCSER1	5.80e-05	200	149	6	a2b9d1cd291d17abddc3ee2e242121412c864b8b
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	JCAD NPR1 STIM2 PDGFB TNFSF10 FYN	5.80e-05	200	149	6	b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a
ToppCell	Control_saline-Endothelial\|Control_saline / Treatment groups by lineage, cell group, cell type	JCAD NPR1 STIM2 PDGFB TNFSF10 DLC1	5.80e-05	200	149	6	3372c488a39fe812fa94e4f0564594186fea3db5
ToppCell	LV-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	CACNB2 GRM2 PDE4DIP PKP2 CCSER1	7.64e-05	130	149	5	a3e12984fb61311e49cc76c59f74f4dffc48faa1
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	TICRR CABLES1 CCDC13 CELSR3 CFAP119	1.36e-04	147	149	5	22d71cf92b957e5a8aa63b13157626d013d6752b
ToppCell	P28-Epithelial-epithelial_progenitor_cell-epi_progenitor\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PLXNA3 ARHGEF38 ARHGAP22 CFAP119 BRSK1	1.75e-04	155	149	5	be575a0096415705dba425002247289ff8f89474
ToppCell	5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(NPW+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PCSK1 CACNB2 STIM2 CELSR3 C6orf141	1.75e-04	155	149	5	498e52e2364ff44d3c0c707ba22468217031f5bd
ToppCell	Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ILDR2 TICRR CACNB2 MARK1 FAT3	1.75e-04	155	149	5	cd7d95cbcad248670e531d80bb83c55e36ebc573
ToppCell	NS-moderate-d_07-13-Epithelial-FOXN4+\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH7 CFAP119 SPAG17 IQCE FAM149A	1.85e-04	157	149	5	410c9d74a2085179cfb39853cb6d330fa98c9c1b
ToppCell	390C-Epithelial_cells-Epithelial-H_(AT1)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	KRT6A KRT6B ARHGAP22 PKP2 C6orf141	2.02e-04	160	149	5	18ae6822915d16699beb9047baeef9b006901a35
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 ARHGAP24 NUTM2A ARHGEF38 CCSER1	2.02e-04	160	149	5	03b88dc7ad41c6ae443cab7e77ec666340bf432e
ToppCell	367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ERBB2 HCN3 FRMD8 CELSR3 KIF19	2.02e-04	160	149	5	955acb023ce4ccfac5073c9d693db87db3856187
ToppCell	390C-Epithelial_cells-Epithelial-H_(AT1)\|390C / Donor, Lineage, Cell class and subclass (all cells)	KRT6A KRT6B ARHGAP22 PKP2 C6orf141	2.02e-04	160	149	5	830f17bad94de05612fe6d53d39e42a4b3f3e2f3
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell-D122\|Adult / Lineage, Cell type, age group and donor	CACNB2 MYH10 MARK1 SMTN BRSK1	2.08e-04	161	149	5	64891f6f2ee1693c8481e951b9346e2f92d602e3
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PRR5 ZP2 CELSR3 DDX50 FYN	2.08e-04	161	149	5	d72c572613f8eff3251cb7b1e9dcc76d193b2f21
ToppCell	5'-Adult-SmallIntestine-Epithelial-neuro-epithelial-EECs\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNB2 KIAA1549 SRCIN1 ADAMTS7 KIF19	2.14e-04	162	149	5	478cf560ef33c5c324142c76417447d4a571a2c9
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PCSK1 CACNB2 SIK1 ARHGEF17 DLC1	2.27e-04	164	149	5	43630a448f4369fa9e4e3eccdf3b9f29cec16c39
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PCSK1 CACNB2 SIK1 ARHGEF17 DLC1	2.27e-04	164	149	5	108fbecb56d69a675d6ce6e826a873ae528f2fd7
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PCSK1 CACNB2 SIK1 ARHGEF17 DLC1	2.27e-04	164	149	5	46208f18325976c89f572f6627aea0582142b92d
ToppCell	367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	KRT6A ERBB2 HCN3 FRMD8 CELSR3	2.27e-04	164	149	5	d2218d50e0e2d19f919dcb460b3840687c082810
ToppCell	3'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-Tuft\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PDE7A FAT3 SRCIN1 BRSK1 CCSER1	2.33e-04	165	149	5	34fd00be2b28716c871ad9fb356de84a299a0c01
ToppCell	356C-Epithelial_cells-Epithelial-D_(AT2)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	KRT6B SRCIN1 DLC1 TMEM125 FAM149A	2.40e-04	166	149	5	2e4cb4056e6b0c43290a5588ff525f5f05b8beee
ToppCell	356C-Epithelial_cells-Epithelial-D_(AT2)\|356C / Donor, Lineage, Cell class and subclass (all cells)	KRT6B SRCIN1 DLC1 TMEM125 FAM149A	2.40e-04	166	149	5	eb8d972326a734549675307e411fc795af66da70
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	ARHGEF38 DYNC2I1 CCDC13 LSM11 C6orf141	2.40e-04	166	149	5	89e2b8453180983533faccb4275867861876d7ee
ToppCell	390C-Myeloid-Macrophage-SPP1+_Macrophage\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	KLF11 ARHGAP22 CCDC13 ZFYVE26 IL3RA	2.47e-04	167	149	5	a48349f189f6a8d563744b0a294c3974f3a18f50
ToppCell	3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Progenitor\|lymph-node_spleen / Manually curated celltypes from each tissue	FAT3 ARHGEF17 ARHGAP22 C6orf141 BAHCC1	2.47e-04	167	149	5	cb396f3edb9e8fdc316091e8e193dbba50e0be0c
ToppCell	5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FAT3 ARHGEF38 SRCIN1 GABRA4 CCSER1	2.54e-04	168	149	5	8072d0496b7b730c4601009eaa69ec5366d26d73
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DYNC2H1 DNAH7 CCDC13 KIF19 SPAG17	2.61e-04	169	149	5	14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f
ToppCell	P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ARHGAP24 FAT3 CCDC80 ADAMTS7 GABRA4	2.68e-04	170	149	5	ba4ba66b624089ed50a9083176386c7941b4c7a3
ToppCell	TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma\|TCGA-Cervix / Sample_Type by Project: Shred V9	ARHGEF38 DNAH7 CABLES1 GMDS FAM149A	2.68e-04	170	149	5	d682178d11d67eb5a02d0c6b3967645e37bcc62a
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CCDC80 MCM5 NME6 PCNT FAM149A	2.68e-04	170	149	5	b1a16600754e0c12f7d39c9221f1b03135833f16
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	TRAF7 TRIOBP BID SART1 PTPRH	2.68e-04	170	149	5	09bcbc7eb3b1d35cf03f01ce2f2fe37373382dd4
ToppCell	TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Mucinous_Adenocarcinoma\|TCGA-Cervix / Sample_Type by Project: Shred V9	ARHGEF38 CABLES1 GMDS TMEM125 FAM149A	2.75e-04	171	149	5	1af575809b3334bfaa019ff26c56e6cb03c82ee8
ToppCell	3'_v3-GI_small-bowel-Mast-Mast_cell_granulo-myelo\|GI_small-bowel / Manually curated celltypes from each tissue	TICRR TNFSF10 ARHGEF40 DLC1 ADAMTS7	2.83e-04	172	149	5	3df11aefc09762fd1f94441324551178e030b249
ToppCell	390C-Epithelial_cells-Epithelial-H_(AT1)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	JCAD KRT6B MARK1 ARHGAP22 PKP2	2.83e-04	172	149	5	bb542f6ca4eb8167129bc84ca1160a54fbb68731
ToppCell	390C-Epithelial_cells-Epithelial-H_(AT1)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	JCAD KRT6B MARK1 ARHGAP22 PKP2	2.83e-04	172	149	5	aff37b9689b0d30ee7097d997d9588efc475c8fd
Drug	phenformin	MARK1 MARK3 SIK1 MARK4 BRSK1	1.83e-06	32	147	5	CID000008249
Drug	CaLam	KRT6A KRT6B ABCC5 KRT6C TMEM132D	5.06e-06	39	147	5	CID004126474
Drug	SC-791	KRT6A KRT6B KRT6C	5.20e-06	6	147	3	CID010291510
Disease	visual impairment and progressive phthisis bulbi (implicated_via_orthology)	MARK1 MARK3 MARK4	4.63e-07	4	145	3	DOID:0070356 (implicated_via_orthology)
Disease	aortic measurement	PCSK1 JCAD MYH10 SMTN ARHGAP22 ARHGEF40 ADAMTS7 LOXL1 FES	4.48e-06	251	145	9	EFO_0020865
Disease	mean arterial pressure	CACNB2 NPR1 STIM2 ARHGAP24 SIK1 PLEKHG1 MARK4 FES AUTS2 GMDS FYN BAHCC1	7.10e-06	499	145	12	EFO_0006340
Disease	platelet crit	JCAD GATAD2A PDGFB ABCC5 KIAA1614 CABLES1 BID KRBA1 ARHGEF40 PTPRH MEIOC SBNO1 CDK13 MARK4 IRS2	7.37e-05	952	145	15	EFO_0007985
Disease	platelet component distribution width	JCAD MARK3 ABCC5 CABLES1 DLC1 PTPRH MEIOC BTBD7 MARK4 IRS2 HERC1 PRRC2A IQCE	9.50e-05	755	145	13	EFO_0007984
Disease	Pachyonychia congenita syndrome	KRT6A KRT6B	1.43e-04	4	145	2	cv:C0265334
Disease	Pachyonychia Congenita, Jadassohn Lewandowsky Type	KRT6A KRT6B	1.43e-04	4	145	2	C1706595
Disease	pachyonychia congenita (is_implicated_in)	KRT6A KRT6B	1.43e-04	4	145	2	DOID:0050449 (is_implicated_in)
Disease	Pachyonychia Congenita, Type 2 (disorder)	KRT6A KRT6B	1.43e-04	4	145	2	C1721007
Disease	Metastatic melanoma	SIK1 MAP3K13 BRSK1 FYN	1.46e-04	54	145	4	C0278883
Disease	Pachyonychia Congenita	KRT6A KRT6B	2.38e-04	5	145	2	C0265334
Disease	Short rib-polydactyly syndrome, Verma-Naumoff type	DYNC2H1 DYNC2I1	2.38e-04	5	145	2	C0432197
Disease	acute lymphoblastic leukemia (implicated_via_orthology)	DBP KMT2A	3.55e-04	6	145	2	DOID:9952 (implicated_via_orthology)
Disease	angina pectoris	DYNC2H1 DHX38 ADAMTS7 LOXL1 FES	3.91e-04	125	145	5	EFO_0003913
Disease	cortical thickness	GATAD2A MARK3 FAT3 ESPNL TRIOBP KIAA1614 ELAC2 PLEKHG1 ZBTB34 ZNF469 ARHGEF40 DLC1 ADAMTS7 AUTS2 KMT2A	3.98e-04	1113	145	15	EFO_0004840
Disease	interleukin-8 measurement	TMEM132D AUTS2 KMT2A	4.72e-04	31	145	3	EFO_0004811
Disease	Hereditary Diffuse Gastric Cancer	ERBB2 MARK1 BID DLC1 KMT2A IRS2 FYN	6.37e-04	293	145	7	C1708349
Disease	Stomach Neoplasms	ERBB2 MARK1 BID DLC1 KMT2A IRS2 FYN	6.90e-04	297	145	7	C0038356
Disease	Malignant neoplasm of stomach	ERBB2 MARK1 BID DLC1 KMT2A IRS2 FYN	7.32e-04	300	145	7	C0024623
Disease	coronary artery disease	JCAD DYNC2H1 CDK12 MARK3 DHX38 TAB2 PLEKHG1 DLC1 ADAMTS7 TMEM132D LOXL1 MARK4 FES GMDS FYN	8.19e-04	1194	145	15	EFO_0001645
Disease	Liver carcinoma	TICRR PDGFB TNFSF10 GDF2 BID CELSR3 KMT2A IRS2 KIF18B	9.38e-04	507	145	9	C2239176
Disease	depressive symptom measurement, response to antidepressant	ANKRD44 ARHGAP22 MAP3K13 CCSER1	9.47e-04	88	145	4	EFO_0007006, GO_0036276
Disease	descending aortic diameter	JCAD ARHGEF40 ADAMTS7 LOXL1	9.47e-04	88	145	4	EFO_0021788
Disease	intraocular pressure measurement	JCAD LRP12 DYNC2H1 TRIOBP ZNF469 DLC1 KMT2A GMDS FYN	9.64e-04	509	145	9	EFO_0004695
Disease	cortical surface area measurement	ILDR2 TICRR MYH10 FAT3 TRIOBP DNAH7 KIAA1614 ELAC2 PLEKHG1 ZNF469 ADAMTS7 RALBP1 FES AUTS2 SPAG17 PRRC2A	9.75e-04	1345	145	16	EFO_0010736
Disease	age-related hearing impairment	TRIOBP SIK1 WDR3 DLC1 NDRG1 AUTS2 SPAG17	1.14e-03	324	145	7	EFO_0005782
Disease	Other specified cardiac arrhythmias	CACNB2 PKP2	1.28e-03	11	145	2	C0348626
Disease	Jeune thoracic dystrophy	DYNC2H1 DYNC2I1	1.28e-03	11	145	2	C0265275
Disease	Nodal rhythm disorder	CACNB2 PKP2	1.28e-03	11	145	2	C0264893
Disease	Ectopic rhythm	CACNB2 PKP2	1.28e-03	11	145	2	C1399226
Disease	CARDIAC CONDUCTION DEFECT, NONSPECIFIC (disorder)	CACNB2 PKP2	1.28e-03	11	145	2	C2748542
Disease	Adenocarcinoma of large intestine	ERBB2 CDK12 DLC1 MARK4	1.31e-03	96	145	4	C1319315
Disease	Agents acting on the renin-angiotensin system use measurement	TICRR CACNB2 STIM2 PLEKHG1 FES AUTS2 TJP2	1.39e-03	335	145	7	EFO_0009931
Disease	Schizophrenia	CACNB2 GRM2 SBNO2 BID SBNO1 ST8SIA2 AUTS2 KMT2A FYN IL3RA PCNT GABRA4	1.43e-03	883	145	12	C0036341
Disease	Diuretic use measurement	TICRR CACNB2 PLEKHG1 FES GMDS	1.52e-03	169	145	5	EFO_0009928
Disease	brain measurement, neuroimaging measurement	CACNB2 MARK3 FAT3 TRIOBP ELAC2 ZBTB34 SBNO1 FES BAHCC1	1.64e-03	550	145	9	EFO_0004346, EFO_0004464
Disease	carotid artery intima media thickness	JCAD DYNC2H1 KIAA1614 CABLES1 LOXL1 GMDS FAM149A CCSER1	1.78e-03	450	145	8	EFO_0007117
Disease	Short Rib-Polydactyly Syndrome	DYNC2H1 DYNC2I1	1.81e-03	13	145	2	C0036996
Disease	Brugada Syndrome 1	CACNB2 PKP2	1.81e-03	13	145	2	C4551804
Disease	Connective Tissue Diseases	ZNF469 PKD2	1.81e-03	13	145	2	C0009782
Disease	cardiovascular disease	CACNB2 NPR1 MARK3 PLEKHG1 ABHD16B FES GMDS BAHCC1	1.96e-03	457	145	8	EFO_0000319
Disease	Antihypertensive use measurement	CACNB2 STIM2 ARHGAP24 PLEKHG1 AUTS2 GMDS	2.04e-03	265	145	6	EFO_0009927
Disease	Saldino-Noonan Syndrome	DYNC2H1 DYNC2I1	2.10e-03	14	145	2	C0036069
Disease	Majewski Syndrome	DYNC2H1 DYNC2I1	2.10e-03	14	145	2	C0024507
Disease	Small cell carcinoma of lung	NDRG1 TMEM132D KMT2A	2.40e-03	54	145	3	C0149925
Disease	Sinus Node Dysfunction (disorder)	CACNB2 PKP2	2.41e-03	15	145	2	C0428908
Disease	microglial activation measurement	ARHGAP24 FAT3 AUTS2	3.09e-03	59	145	3	EFO_0010940
Disease	infant grey matter volume measurement	CACNB2 CDK13	3.48e-03	18	145	2	EFO_0008368
Disease	cardiomyopathy (is_implicated_in)	POLG TAB2	3.88e-03	19	145	2	DOID:0050700 (is_implicated_in)
Disease	Meningioma	TRAF7 PDGFB	3.88e-03	19	145	2	C0025286
Disease	red blood cell density measurement	KLF11 PDGFB CDK12 GDF2 ARHGEF40 ABHD16B MARK4 TJP2 GMDS IRS2 FYN	4.24e-03	880	145	11	EFO_0007978
Disease	cerebellum white matter volume change measurement, age at assessment	ADAMTS7 TJP2	4.30e-03	20	145	2	EFO_0008007, EFO_0021498
Disease	ovarian neoplasm	ERBB2 TNFSF10 CDK12 DLC1	4.39e-03	134	145	4	C0919267
Disease	Precursor B-cell lymphoblastic leukemia	AUTS2 KMT2A	4.74e-03	21	145	2	C1292769
Disease	haptoglobin measurement	DHX38 DLC1	4.74e-03	21	145	2	EFO_0004640
Disease	Malignant neoplasm of ovary	ERBB2 TNFSF10 CDK12 DLC1	4.74e-03	137	145	4	C1140680

Protein segments in the cluster

Peptide	Gene	Start	Entry
SGSVRRKVSGSHVSR	nan	146	A8MZ25
RGDLTADSVQRGSRH	CAMLG	136	P49069
RHRSSSTRSGGGDLT	ERBB2	1046	P04626
RGSLGHRSAAAAARL	BAHCC1	16	Q9P281
GGGSSNSRERHRLVS	CDK12	26	Q9NYV4
ASRGILGLSRQSHAR	ARHGEF40	1496	Q8TER5
RSGSIRRTHSDTQAT	DNAH10OS	6	P0CZ25
SVSGDHSGTLRRSQS	ARHGEF38	41	Q9NXL2
VRASLSRGADGSRHI	GRM2	106	Q14416
EVTRTHKREGSGRFS	GSDMD	171	P57764
FRSRRGQTVLGSIDH	ANKRD20A5P	6	A0PJZ0
TRGRHSVGFSSSRNK	CCSER1	111	Q9C0I3
GRGQASSAVSDRGHR	FLG	401	P20930
QSESAHGRTRTSTGR	FLG	1126	P20930
HGRTRTSTGRRQGSH	FLG	1131	P20930
SGIGHRQASSAVRDS	FLG	1371	P20930
RQASSAVRDSGHRGS	FLG	1376	P20930
GHSEDSERRSGSASR	FLG	2251	P20930
HQESTRGRSAGRSGR	FLG	2396	P20930
SESAHGRTRTSTGRR	FLG	3396	P20930
GRTRTSTGRRQGSHH	FLG	3401	P20930
QASSAVRDSGHRGSS	FLG	3646	P20930
SHQESTRGRSAGRSG	FLG	3691	P20930
ERHLRSAGSRLTLSG	NPR1	521	P16066
RDSRGRTGLHLAAAR	ANKRD46	41	Q86W74
GQRGGSEASKSRSRH	CDK13	221	Q14004
FVSETRRRGGLGRAH	ADAMTS7	106	Q9UKP4
DDVRAVGRSSSHRAL	ABHD16B	36	Q9H3Z7
HRSGTSRGLSRQETF	CACNB2	541	Q08289
FLRHTGRSRGIERST	CCDC80	51	Q76M96
RRVEHGSGLTRTPSS	RALBP1	16	Q15311
GASGSSSRKRHRSRE	CPSF7	411	Q8N684
AASTRRRSASATHGD	IQCE	631	Q6IPM2
GHVAAGSTLARRKRS	GDF2	306	Q9UK05
RHRGRVSPSDADSTV	KIAA1549	1406	Q9HCM3
RALRRSSHGSFTRGS	ARHGEF17	1711	Q96PE2
SATALVSRTGRHSER	GATAD2A	556	Q86YP4
VSRTGRHSERTVSAG	GATAD2A	561	Q86YP4
RGRRDLGLETTSAHS	FAM201A	66	Q5SY85
GSRTSGRQRFSHSDA	FLG2	1336	Q5D862
HGQSTQRGSRTTGRR	FLG2	1406	Q5D862
RGSRTTGRQRSSHSE	FLG2	1641	Q5D862
TGSRTTGRRSSGHSE	FLG2	1791	Q5D862
TQSGSSTTGRRRSGH	FLG2	1866	Q5D862
STTGRRRSGHSESSD	FLG2	1871	Q5D862
TQRGSRTTGRRASGH	FLG2	2016	Q5D862
RTTGRRASGHSEYSD	FLG2	2021	Q5D862
RTAGRRGSGHSESSD	FLG2	2096	Q5D862
RTTGRRGSGHSESSD	FLG2	2246	Q5D862
LTAAHGSSVNRRTRS	ESPNL	156	Q6ZVH7
HSSSRRGFSANSARL	KRT6C	11	P48668
RKSHRGQERGTSEAG	KRBA1	186	A5PL33
SIRISHGARLTVSGS	IGDCC3	216	Q8IVU1
GRADTGRGSHKRSRS	LSM11	266	P83369
RSRHSGSLALVSADG	LRP12	611	Q9Y561
HGIVRRSSSFNTGRI	GMDS	51	O60547
SSSGHRVRLTEGQGS	MGA	286	Q8IWI9
SGARQHERDSDRRSS	MCM5	591	P33992
GLSEGRRRHGFTVRS	FAM149A	191	A5PLN7
HSSSRRGFSANSARL	KRT6A	11	P02538
RSHRSSVSSVGARAA	FRMD8	16	Q9BZ67
SSLSAFDRSHRGRIS	KATNIP	901	O60303
VSDSESRRSTPRGHG	JCAD	66	Q9P266
RSHRSSVSSVGARAA	FRMD8P1	16	Q9BZ68
SGPSARGRSAVTRRH	HERC1	2866	Q15751
TITQGSRDGHRSPAR	KIAA1614	396	Q5VZ46
RARTSVSQQRHGGSA	LOXL1	141	Q08397
EHRNRGASSKRDGTS	DYNC2I1	296	Q8WVS4
HRRGTARLGLSTVTG	C9orf131	956	Q5VYM1
GAREAESRAHTGSSS	GPATCH4	401	Q5T3I0
RSHSGGELESLARGR	PDGFB	66	P01127
ELRALTRGHGATRTV	PLXNA3	601	P51805
HSSSRRGFSANSARL	KRT6B	11	P04259
VRSRAGFESERRGSH	PDE7A	71	Q13946
GSSVTSLDGTRSRSH	NDRG1	331	Q92597
SLDGTRSRSHTSEGT	NDRG1	336	Q92597
SSRSGRLSLHGDIRL	FAM214B	491	Q7L5A3
GSRSGQSSRGERHRS	HRNR	261	Q86YZ3
SGESKGFHRSSSRER	AUTS2	191	Q8WXX7
SREHGRTRSGTRSES	PHRF1	1011	Q9P1Y6
GSASTRHVFGSRLQR	GABRA4	471	P48169
RAHGEAGAGRVRTSA	HRES1	176	P13985
SSVNVSDRGGRTALH	ANKRD44	131	Q8N8A2
EGSRRAASTGGSHLT	OR5C1	236	Q8NGR4
ARTLHASLSRAGRSQ	HCN3	676	Q9P1Z3
RTSAGHEEGATRLAR	MROH1	1296	Q8NDA8
AGSERASSTHAKGER	KIF18B	256	Q86Y91
RVASSSVSHGRSRIA	KIF18B	786	Q86Y91
RLHLGSARRAAGSDA	PCNT	2951	O95613
RRSRSFEVTGQGLSH	KIF19	891	Q2TAC6
RRGNSRGSHSDFAAI	MAP3K13	591	O43283
QGGRRRHSSETFSST	IRS2	1141	Q9Y4H2
GYRSVRERTSTSGTH	ABCC5	16	O15440
SDHRSVGGRSSRATS	ARHGAP24	611	Q8N264
DRSSVHGSAARTRAS	CFAP119	31	A1A4V9
ARGTHSGSVLERESS	GALR2	326	O43603
SRSHPSTRGDSQATR	FRMD1	436	Q8N878
RSGVGRRTITSLVSH	DYNC2H1	2656	Q8NCM8
RHVIRALVGERGSSS	ESPL1	226	Q14674
GSQSSHILVRGRSAA	IL3RA	176	P26951
RNLSHRSLSIGRASG	CABLES1	426	Q8TDN4
QARTGASRVHAAGRR	C6orf141	216	Q5SZD1
GRRLSSGSVHSAADS	FRMPD2	276	Q68DX3
GVNSSSHTGTLRTRG	FYN	66	P06241
HVGRLGSSRSVTSLG	CCDC13	496	Q8IYE1
LSGQTRTIARGRSHG	CENPT	51	Q96BT3
RTIARGRSHGARSVG	CENPT	56	Q96BT3
SERRGVLSTTGHSTN	DNAH7	3981	Q8WXX0
RASVRADVGRGHLVT	FAT3	2606	Q8TDW7
SYIHRSGRTGRAGRT	DDX50	471	Q9BQ39
HSQRSRSVSGASTGL	BRSK1	426	Q8TDC3
RSGRRLADSESLGHG	BTBD7	1086	Q9P203
GNRSSHSRLGRIEAD	BID	61	P55957
RGSSSRSTFHGEQLR	MARK1	606	Q9P0L2
HGDGRQEVTSRTSRS	MARK3	21	P27448
RGSTIRSTFHGGQVR	MARK4	561	Q96L34
ARSDELSRHRRTHTG	KLF10	411	Q13118
ARSDELSRHRRTHTG	KLF11	436	O14901
GLRSIGSRRHSTSSL	KMT2A	2186	Q03164
RTVISSGGEERLASH	KMT2A	2686	Q03164
GTASGHRAGLTSRDT	DBP	176	Q10586
SSSRQRTSGSGFHRE	WTAP	281	Q15007
RSGLISTSGRVDREH	CELSR3	491	Q9NYQ7
LLSVTVTRGSGRASH	CELSR3	1821	Q9NYQ7
LGALTHGDRRATESR	SBNO1	1016	A3KN83
FSSSRSGRRQLHLEG	MYH10	1936	P35580
RHSTSSSEQEREGGR	FES	406	P07332
TTARDSQGRGRAHTG	NUTM2A	676	Q8IVF1
HSRAAPSRGTARLDS	NUTM2E	631	B1AL46
TTARDSQGRGRAHTG	NUTM2E	676	B1AL46
HRRARAGSSSGALGL	POLG	31	A0A3B3IS91
SHRTRGGDNSRVNRT	MEIOC	646	A2RUB1
SGGRRRRLTLHSVFS	RNF19B	26	Q6ZMZ0
HSVFSASARGRRARA	RNF19B	36	Q6ZMZ0
REDARRSNGIRTGHS	TMEM132D	241	Q14C87
RIHSDTFASGGERAR	TAB1	336	Q15750
GREGSRMNGSRTLTH	TAB2	91	Q9NYJ8
AAAGGTSIRRHSVSE	PRR5	271	P85299
RRQRGSETGSETHES	PRRC2A	1101	P48634
HTASTLERGTSRGAG	SPPL2C	556	Q8IUH8
SSTGRRHTLAEVSTR	SIK1B	466	A0A0B4J2F2
SSTGRRHTLAEVSTR	SIK1	466	P57059
GGRGTIRSAVNSLHS	ST8SIA2	36	Q92186
LGALTHGDRRATESR	SBNO2	876	Q9Y2G9
RGTSDERAAQRGHRA	PPP1R26	61	Q5T8A7
SGVGASLTRSNRHRL	DLC1	986	Q96QB1
RGESGLSLERHRSTL	TRIOBP	226	Q9H2D6
SRGGRLGSSREHQSF	ARHGAP4	76	P98171
GTRIVDHADGTRITT	SPAG17	1446	Q6Q759
SSLRGHRRASSGDRL	ARHGAP22	466	Q7Z5H3
HRRASSGDRLKDSGS	ARHGAP22	471	Q7Z5H3
SERSRLNSHGGRSRS	TJP2	156	Q9UDY2
LDTAGGAARHSRVRR	TICRR	11	Q7Z2Z1
HGVSQRRGVRDSSLV	ELAC2	226	Q9BQ52
GGRSTDAHSRGRSDD	RBMXL3	436	Q8N7X1
VGESYRSRSTLGHSR	RNF111	331	Q6ZNA4
GRRFSNVGLVHTSER	SRCIN1	41	Q9C0H9
HLRGRRATGSAATAA	STIM2	21	Q9P246
GNSHEARGGSRFERS	ILDR2	446	Q71H61
ARGGSRFERSESRAH	ILDR2	451	Q71H61
RHQGSVTALAVSRGR	TRAF7	641	Q6Q0C0
RGSFGLTDTRNTTHG	NME6	116	O75414
SRHSSRSERDGGSER	DHX38	176	Q92620
AGSVASSSGSLRHRR	TMEM201	511	Q5SNT2
GTRHSAVLRDLRSGT	TNXA	201	Q16473
GHSSRRRGSISSGVS	PKD2	821	Q13563
GRRGAEAEARSSTHG	SART1	66	O43290
ALTAAHSRSGSEGRT	ZNF469	2041	Q96JG9
HSRSGSEGRTPERAS	ZNF469	2046	Q96JG9
VSSGSNASRRRNGLH	TAPR1	216	Q14CZ0
TETSSSGHRIVRRAS	PLEKHG1	596	Q9ULL1
SGHRIVRRASSAGES	PLEKHG1	601	Q9ULL1
GRRSHTGSVGNTRSS	TOGARAM1	1441	Q9Y4F4
TSRITIGGHRSDVRT	WDR3	406	Q9UNX4
IGGHRSDVRTLSFSS	WDR3	411	Q9UNX4
RVAAHITGTRGRSNT	TNFSF10	121	P50591
GRAGTRSTAHTNITV	PTPRH	161	Q9HD43
GQLSAGRRHETTSSI	TMEM125	201	Q96AQ2
ERESRSASRSGSAHG	TRA2B	11	P62995
VSSRHRRATGATEAE	ZP2	636	Q05996
SGSRDGLQSRLHRLS	ZFYVE26	716	Q68DK2
GVSRAGTTSRQRHFD	PKP2	201	Q99959
DSSGRRAHLTVGQAA	PKP2	311	Q99959
RLVHSNDGTRTARTT	SMTN	671	P53814
RSGRSLGTADVHFER	ALYREF	141	Q86V81
RSRLQEEGHSDRGSS	ZBTB34	191	Q8NCN2
QLEHRLTSTARGRGS	PDE4DIP	1871	Q5VU43
SRRGDLHVTLTSAAG	PCSK1	516	P29120